Yes, note Bell Potter NPAT for FY21
old A$38.9m, now minus 56% which I think is still generous...at $17.2m
Compare that to uber ramper @wombat777 who had his retailer based fantasy NPAT estimate at A$1 Billion.
A hearted poster with multiple top MSB posts, all in fantasy land as I have posted many times even before FDA "delay".
Beware the HC piped pipers.
whilst Bell Potter likely much closer to the mark than any uber ramper will ever be, I would temper that with an observation.
Bell Potter have reduced NPAT obviously...and shuffled around some balance sheet items
1. for FY21 by -56% and
2. for FY22 by - 90%
Yet adjusted "valuation" from $7.30 to just $7.....
Yeh, righto.
**and a special mention for my mate @benelong
TEMCELL royalties expected to be MINUS 32% for FY21 over FY20.
Updated Broker Report: Bel Potter, page-19
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11031 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 14844 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |